Abstract Background Acute pulmonary embolism (APE) remains a diagnostic challenge due to a variable clinical presentation and the lack of a reliable screening tool. MicroRNAs (miRNAs) regulate gene expression in a wide range of pathophysiologic processes. Circulating miRNAs are emerging biomarkers in heart failure. type 2 diabetes and other disease states; however. https://www.espumasyterciopelo.com/product-category/sashes/
MicroRNA-134 as a potential plasma biomarker for the diagnosis of acute pulmonary embolism
Internet 2 hours 18 minutes ago cormxofkyyjjWeb Directory Categories
Web Directory Search
New Site Listings